ABSTRACT
INTRODuCTION
The no-reflow phenomenon is associated with microvascular dysfunction. It has been described in 20-40% of patients with acute ST-segment elevation myocardial infarction (STEMI), despite restoration of TIMI 3 myocardial flow.
1
It is associated with a fivefold increase in the risk of myocardial infarction and a fourfold increase in the risk of death.
2 No-reflow has also been associated with an increased risk of left ventricular systolic dysfunction, reduced left ventricular ejection fraction, left ventricular remodeling, malignant ventricular arrhythmias, heart failure, and cardiac rupture.
3,4
None of the prophylactic and therapeutic approaches currently available are effective to prevent this phenomenon.
5-8

CASE PRESENTATION
A During stent deployment, the distal coronary pressure was measured through the tip of the pressure-wire. The recorded mean value was 27 mmHg. A tall systolic wave was identified in the pattern of the pressure curve ( Figure 3 ).
The ECG recording that was performed after the procedure showed the persistence of ST-segment elevation.
The first high-sensitivity troponin T value was in the normal range. However, 12 hours after the procedure, it reached a peak value of 3.78 ng/ml, which suggested a large area of necrosis. Left ventricular ejection fraction was The patient and the institution agreed with publication of this case.
DISCuSSIONS
The patient was an early presenter, with recently installed exertional angina. The ECG recording revealed the supra-acute phase of an acute myocardial infarction, in accordance with the above mentioned data. However, the angiographic result, as described by the MBG, was suboptimal, in spite of the TIMI 3 flow, suggesting the presence of MVO. 9 Moreover, the absence of ST-segment resolution on the post-procedural ECG recording was also consistent with no-reflow phenomenon. Both STsegment resolution and MBG have prognostic utility after primary percutaneous coronary intervention (PCI). 10 Both parameters predict mortality, left ventricular dysfunction, and clinical heart failure. 11 The patient developed an apical left ventricular aneurysm, and his ejection fraction was depreciated.
Coronary blood flow interrogation by Doppler echocardiography emerged as a useful diagnostic tool for the noreflow phenomenon following acute STEMI. 12 The increase in microvascular impedance secondary to microcirculatory obstruction is associated with a specific Doppler pattern. Among these parameters, DDT below 600 msec and the decrease of peak systolic velocity, up to the reversal of the systolic flow are the most powerful markers of microcirculatory dysfunction. Short time to reperfusion has been shown to be a powerful predictor of a good outcome in STEMI patients.
However, total ischemic time is far from being the sole determinant of left ventricular remodeling or of an adverse prognosis. 15 The platelet fresh component of the thrombus is unstable and prone to embolization into the distal microcirculation, causing MVO and interstitial inflammatory damage. 16 The embolism that occurs several days before the onset of symptoms was recently suggested by In the infarcted wall, MVO could impede coronary blood ejection into the venous circulation and could therefore cancel the benefit conferred in certain cases by coronary collateralization. This increases CWP by means of a large and tall systolic wave that defines the hemodynamic spectrum of MVO. 18 On the other hand, CWP is also influenced by interstitial pressure as interstitial edema compresses capillaries and increases the intravascular pressure. 19 The edema and inflammation surrounding the infarct zone are important determinants of left ventricular remodeling. 
CONCLuSIONS
In conclusion, there is more than meets the eye to coronary revascularization in the setting of an acute STEMI.
Microvascular obstruction and interstitial edema are increasingly recognized as main players in the determinism of left ventricular remodeling. Moreover, MVO is not a temporally precisely located process. It starts before symptoms onset and continues during and after revascularization. The development of new treatment strategies will be a quest of the years to come. In this regard, the two different CWP patterns will differentiate the mechanism of MVO and will help select the most appropriate therapy.
